Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “ras”

843 pharma patents match "ras" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 843
Index total 30,257
Page 16 / 36

Quick answer

This filtered view shows 843 pharmaceutical patents matching "ras" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

843 results for “ras” · 30,257 patents in full index Clear search

  1. US 9833427

    Creatine ester anti-inflammatory compounds and formulations

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted
  2. US 9808488

    Isolated populations of renal stem cells and methods of isolating and using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted
  3. US 9808428

    Compositions and methods for the delivery of therapeutics

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted
  4. US 9789205

    Compositions and methods for gene therapy

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted
  5. US 9782464

    Methods and compositions for inhibiting diseases of the central nervous system

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  6. US 9782387

    Compositions and methods for treating hematological malignancies

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  7. US 9783855

    Cancer screening by detection of ultrastructural and molecular markers

    Northwestern University · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  8. US 9777050

    Peptides and compositions for prevention of cell adhesion and methods of using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Oct 3, 2017 · Expires Sep 28, 2037

    granted
  9. US 9770469

    Methods of reprogramming renal cells

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  10. US 9771567

    Klotho variant polypeptides

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  11. US 9765340

    RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of CAMP-related ocular disorders

    Arrowhead Pharmaceuticals, Inc. · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  12. US 9758831

    Methods of predicting clinical course and treating multiple sclerosis

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  13. US 9757382

    Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways

    Asana BioSciences, LLC · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  14. US 9737571

    Compositions of aquatic origin for prevention of cell adhesion and methods of using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted
  15. US 9732124

    Peptides and compositions for prevention of cell adhesion and methods of using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted
  16. US 9713459

    Method and system for in vivo hydrogen peroxide detection with ultrasound

    The Regents of the University of California · Granted Jul 25, 2017 · Expires Jul 20, 2037

    granted
  17. US 9707215

    Inhibitors of hepatitis C virus polymerase

    COCRYSTAL, DISCOVERY, INC. · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted
  18. US 9707221

    Methods of treating cancer patients with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted
  19. US 9707283

    Genetically modified babesia parasites expressing protective tick antigens and uses thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted
  20. US 9693999

    Small molecule RNase inhibitors and methods of use

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jul 4, 2017 · Expires Jun 29, 2037

    granted
  21. US 9694111

    Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent

    Lutonix, Inc. · Granted Jul 4, 2017 · Expires Jun 29, 2037

    granted
  22. US 9688697

    RNA polymerase I inhibitors and uses thereof

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jun 27, 2017 · Expires Jun 22, 2037

    granted
  23. US 9676771

    Compounds for inhibiting drug-resistant strains of HIV-1 integrase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  24. US 9675662

    Compositions for inhibition of RNA polymerase I and methods of production and use thereof

    The Board of Regents of the University of Oklahoma · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted